Recursion Pharmaceuticals, Inc. (RXRX) NASDAQ

5.57

-0.2021(-3.50%)

Updated at August 18 02:43PM

Currency In USD

Valuation

Market Cap1.85B
Enterprise Value1.37B
P/E Ratio-3.54
PEG Ratio6.27
Price/Sales Ratio36.54
Price/Book Ratio2.5
Enterprise/Revenue29.71
Enterprise/EBITDA-3.28

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-10.07
Operating Margin-10.08

Management Effectiveness

Return On Assets-0.5
Return On Equity-0.76

Income Statement

Revenue58.84M
Revenue/Share0.15
Gross Profit13.6M
EBITDA-426.72M
Net Income-463.66M
Diluted EPS-1.69

Balance Sheet

Total Cash528.22M
Total Cash/Share1.27
Total Debt88.08M
Total Debt/Equity0.1
Current Ratio3.58
Book Value Per Share2.2

Price History

52-Week Change-22.94
52-Week High12.36
52-Week Low3.79
Moving Average 50 Days5.48
Moving Average 200 Days6.18

Statistics

Average Volume27.87M
Shares Outstanding427.31M
% Held by Institutions74.03

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A